Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

DJ Kwekkeboom, BL Kam, M Van Essen… - Endocrine-related …, 2010 - erc.bioscientifica.com
Somatostatin receptor imaging (SRI) with [111In-DTPA0] octreotide has proven its role in the
diagnosis and staging of gastroenteropancreatic neuroendocrine tumors (GEPNETs). Newer …

[HTML][HTML] Tumor-induced osteomalacia

WH Chong, AA Molinolo, CC Chen… - Endocrine-related …, 2011 - erc.bioscientifica.com
Somatostatin receptor imaging (SRI) with [111 In-DTPA 0] octreotide has proven its role in
the diagnosis and staging of gastroenteropancreatic neuroendocrine tumors (GEPNETs) …

European association of nuclear medicine practice guideline/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of …

D Taïeb, RJ Hicks, E Hindié, BA Guillet… - European journal of …, 2019 - Springer
Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …

EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma

D Taïeb, HJ Timmers, E Hindié, BA Guillet… - European journal of …, 2012 - Springer
Purpose Radionuclide imaging of phaeochromocytomas (PCCs) and paragangliomas
(PGLs) involves various functional imaging techniques and approaches for accurate …

Current approaches and recent developments in the management of head and neck paragangliomas

D Taïeb, A Kaliski, CC Boedeker, V Martucci… - Endocrine …, 2014 - academic.oup.com
Head and neck paragangliomas (HNPGLs) are rare neuroendocrine tumors belonging to
the family of pheochromocytoma/paraganglioma neoplasms. Despite advances in …

[PDF][PDF] Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome

AN Madsen, G Hansen, SJ Paulsen… - Journal of …, 2010 - researchgate.net
The availability of useful animal models reflecting the human obesity syndrome is crucial in
the search for novel compounds for the pharmacological treatment of obesity. In the current …

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with 111In-Pentetreotide

DJ Kwekkeboom, EP Krenning, K Scheidhauer… - …, 2009 - karger.com
Dik J. Kwekkeboom a Eric P. Krenning a Klemens Scheidhauer b Val Lewington c Rachida
Lebtahi d Ashley Grossman e Pavel Vitek f Anders Sundin g Ursula Plöckinger h and the …

Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results

KP Koopmans, ON Neels, IP Kema, PH Elsinga… - Critical reviews in …, 2009 - Elsevier
Neuroendocrine tumors can originate almost everywhere in the body and consist of a great
variety of subtypes. This paper focuses on molecular imaging methods using nuclear …

[PDF][PDF] Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma

F Forrer, I Riedweg, HR Maecke… - QJ Nucl Med Mol …, 2008 - researchgate.net
Aim. Paragangliomas and pheochromocytomas are rare tumors arising from chromaffin
cells. Approximately 10% are malignant. Treatment options are limited in metastatic …

Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic …

I Ilias, CC Chen, JA Carrasquillo… - Journal of Nuclear …, 2008 - Soc Nuclear Med
We compared functional imaging modalities including PET with 6-18F-fluorodopamine (18F-
DA) with 123I-metaiodobenzylguanidine (123I-MIBG) and somatostatin receptor …